Literature DB >> 24631764

Cucurbitane-type triterpenoids from the stems and leaves of Momordica charantia.

Gao-Ting Zhao1, Jie-Qing Liu2, Yuan-Yuan Deng3, Hai-Zhou Li1, Jian-Chao Chen2, Zhi-Run Zhang2, Lin Zhou2, Ming-Hua Qiu4.   

Abstract

Six new cucurbitane-type triterpenoids, karavilagenin F (1), karavilosides XII and XIII (2, 3), momordicines VI, VII, and VIII (4, 5 and 6), along with four known ones, 5β,19-epoxy-25-methoxycucurbita-6,23-diene-3β,19-diol (7), 5β,19-epoxycucurbita-6, 23-diene-3β,19,25-triol (8), kuguacin R (9), and (19R,23E)-5β,19-epoxy-19-methoxycucurbita-6,23,25-trien-3β-ol (10), were isolated from the stems and leaves of Momordica charantia L. Their chemical structures were elucidated by extensive 1D NMR and 2D NMR (HSQC, HMBC, COSY, and ROESY), MS experiments, and CD spectrum. Compound 6 showed weak cytotoxicity against five human cancer cells lines with IC50 values of 14.3-20.5μmol/L.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cucurbitaceae; Cucurbitane-type triterpenoids; Cytotoxicity; Momordica charantia

Mesh:

Substances:

Year:  2014        PMID: 24631764     DOI: 10.1016/j.fitote.2014.03.005

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  11 in total

1.  Cucurbitane-Type Triterpenoids from the Vines of Momordica charantia and Their Anti-inflammatory Activities.

Authors:  Hung-Tse Huang; Li-Jie Zhang; Hui-Chi Huang; Syh-Yuan Hwang; Chia-Lun Wu; Yu-Chi Lin; Chia-Ching Liaw; Yung-Yi Cheng; Susan L Morris-Natschke; Chung-Yi Huang; Kuo-Hsiung Lee; Yao-Haur Kuo
Journal:  J Nat Prod       Date:  2020-05-01       Impact factor: 4.050

Review 2.  Bitter melon: a panacea for inflammation and cancer.

Authors:  Prasad R Dandawate; Dharmalingam Subramaniam; Subhash B Padhye; Shrikant Anant
Journal:  Chin J Nat Med       Date:  2016-02

Review 3.  Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics.

Authors:  Richard T Arkwright; Rahul Deshmukh; Nikhil Adapa; Ryan Stevens; Emily Zonder; Zhongyu Zhang; Pershang Farshi; Reda Saber Ibrahim Ahmed; Hossny Awad El-Banna; Tak-Hang Chan; Q Ping Dou
Journal:  Anticancer Agents Med Chem       Date:  2015       Impact factor: 2.505

Review 4.  Recent Advances in Momordica charantia: Functional Components and Biological Activities.

Authors:  Shuo Jia; Mingyue Shen; Fan Zhang; Jianhua Xie
Journal:  Int J Mol Sci       Date:  2017-11-28       Impact factor: 5.923

Review 5.  An Update Review on the Anthelmintic Activity of Bitter Gourd, Momordica charantia.

Authors:  Sutthaya Poolperm; Wannee Jiraungkoorskul
Journal:  Pharmacogn Rev       Date:  2017 Jan-Jun

6.  Wild Bitter Melon Leaf Extract Inhibits Porphyromonas gingivalis-Induced Inflammation: Identification of Active Compounds through Bioassay-Guided Isolation.

Authors:  Tzung-Hsun Tsai; Wen-Cheng Huang; How-Ting Ying; Yueh-Hsiung Kuo; Chien-Chang Shen; Yin-Ku Lin; Po-Jung Tsai
Journal:  Molecules       Date:  2016-04-06       Impact factor: 4.411

7.  Investigation of Biological Activities of Wild Bitter Melon (Momordica charantia Linn. Var. Abbreviata Ser.).

Authors:  Thi My Hanh Pham; Dai-Hung Ngo; Dai-Nghiep Ngo; Thanh Sang Vo
Journal:  Biomolecules       Date:  2019-05-30

8.  Momordica charantia Extract Protects against Diabetes-Related Spermatogenic Dysfunction in Male Rats: Molecular and Biochemical Study.

Authors:  Gamal A Soliman; Rehab F Abdel-Rahman; Hanan A Ogaly; Hassan N Althurwi; Reham M Abd-Elsalam; Faisal F Albaqami; Maged S Abdel-Kader
Journal:  Molecules       Date:  2020-11-11       Impact factor: 4.411

9.  Wound healing by topical application of Momordica charantia L. formulations on mice.

Authors:  William Antonio Sagástegui-Guarniz; Carmen R Silva-Correa; Víctor E Villarreal-La Torre; María V González-Blas; Walter O Sagástegui-Guarniz; Abhel A Calderón-Peña; Cinthya L Aspajo-Villalaz; José L Cruzado-Razco; Julio Hilario-Vargas
Journal:  Vet World       Date:  2021-10-22

Review 10.  A detailed review on the phytochemical profiles and anti-diabetic mechanisms of Momordica charantia.

Authors:  Sunday Faith Oyelere; Oluwatobi Hezekiah Ajayi; Titilayo Eunice Ayoade; George Bueno Santana Pereira; Bolaji Charles Dayo Owoyemi; Ajibola Olaoluwa Ilesanmi; Olalekan Amos Akinyemi
Journal:  Heliyon       Date:  2022-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.